Related Experiment Video
Updated: Nov 3, 2025

07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.6K
Assessing consistency across functional screening datasets in cancer cells
Ling Cai1,2,3, Hongyu Liu1, John D Minna3,4,5,6
1Quantitative Biomedical Research Center, Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Bioinformatics (Oxford, England)
|June 3, 2021
Summary
This study introduces a new method to assess the consistency of cancer cell line screening data, revealing poor concordance in many datasets. A web tool, the Functional Data Consistency Explorer (FDCE), is now available for global data consistency analysis.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- High-throughput screening in cancer cell lines is crucial for identifying therapeutic agents and targets.
- Previous consistency assessments were limited, examining only two datasets and selected features, potentially overlooking global data concordance issues.
Purpose of the Study:
- To develop and present novel measures for assessing the global consistency of functional genomics and compound screening data in cancer cell lines.
- To create an accessible web application for users to explore and visualize data consistency.
Main Methods:
- Assembled nine compound screening datasets and three functional genomics datasets.
- Derived direct and indirect measures of data consistency, including associations with copy number-adjusted gene expression data.
- Integrated consistency measures into an interactive web application, the Functional Data Consistency Explorer (FDCE).
Main Results:
- Identified significant inconsistencies across multiple cancer cell line screening datasets.
- Developed a comprehensive approach to assess global data consistency beyond selected features.
- The Functional Data Consistency Explorer (FDCE) enables interactive querying and visualization of feature-specific data consistency.
Conclusions:
- Existing cancer cell line screening data exhibit considerable inconsistencies, impacting the reliability of therapeutic agent and target identification.
- The developed functional data consistency measures and the FDCE web tool provide a valuable resource for researchers to evaluate data reliability.
- Promotes more rigorous assessment of high-throughput screening data for improved translational research in cancer therapy.

